Phase 4 N=122 Menopur Mixed Protocol
Infertility
Primary: Fertilization Rate — 63.14; 59.56 percentage of oocytes retrieved
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=64 Ultrasound Guided Pain Control Versus Standard Treatment in Emergency Department HIP Fracture Patients
Hip Fracture
Primary: Pain Score at 30 Minutes — 1.94; 2.05; 5.13 units on a scale — p=<.0001
Phase 2 N=24 Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
Primary: Number of Participants With Any Adverse Event (AE) or Any Serious Adverse Event (SAE) — 6; 9; 8; 4 Participants
Phase 4 N=15 Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Treatment Resistant Nephrotic Syndrome
Primary: Significant Reduction in Proteinuria to Remission Levels During the Treatment Period (Includes Complete and Partial Remission, as Defined in the Outcome Measure…
Phase 3 N=506 Varenicline and Bupropion for Smoking Cessation
Smoking
Primary: Prolonged Smoking Abstinence Rates at 12 Weeks in Cigarettes Smokers. — 132; 111 participants — p=0.03
Phase 3 N=18 Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Breast Cancer
Primary: Number of Participants With Urine and Serum NTx and Serum CTx Within Normal Range at 12 Months — 13 participants
Phase 4 N=110 REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
Psoriatic Arthritis
Primary: Percentage of Participants With Improvement of ≥ 0.50 Units From Baseline to Month 24 in the HAQ DI — 56.0 percentage of participants
N/A N=21 Physical Training and the Incretin Effect
Healthy
Primary: Incretin Effect (the % of Insulin Secreted Due to the Release of the Intestinal Hormones Glucagon Like Peptide-1 (GLP-1 and Glucose-dependent Insulinotropic Peptide…
Phase 4 N=375 Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes · Hyperglycemia
Primary: Mean Blood Glucose Levels (Measured in mg/dL) at Randomization Are Compared to Mean Blood Glucose Levels After First Day of Treatment Among Subjects Treated With Basal…
Phase 4 N=334 Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
Hypertension
Primary: Change in Mean Sitting Diastolic Blood Pressure (MSDBP) at Week 8 — -10.1; -8.8 mmHg — p=0.1339
N/A N=50 Blood Pressure Telemonitoring and Goal Blood Pressure in Diabetes
Diabetes · Hypertension
Primary: Mean Change in Systolic Blood Pressure — -3.08; 2.72 Millimeters of Mercury
Phase 2 N=80 A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
Lymphocytic Leukemia, Chronic
Primary: Objective Response Rate (ORR) — 48.8; 66.7 Percentage of participants — p=0.0779
Phase 4 N=125 The Use of Statins Following a Left Atrial Catheter Ablation Procedure to Prevent Atrial Fibrillation
Atrial Fibrillation · Arrhythmia · Inflammation
Primary: Percentage of Subjects Without Symptoms of Atrial Fibrillation at 3 Months — 95; 93.5 Percentage of subjects — p=0.75
Phase 2 N=20 A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)
Candidiasis, Esophageal · Candidiasis, Invasive · Aspergillosis
Primary: Percentage of Participants With an Overall Favorable Response to Therapy — 66.7; 62.5 Percentage of Participants
Phase 4 N=22 Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
Anxiety Disorder
Primary: Hamilton Anxiety Scale (HAM-A) Score at Study Endpoint. — 16.27; 15.82; 13.64; 15.55 units on a scale — p=<0.05